KalVista Pharmaceuticals Statistics
Total Valuation
KALV has a market cap or net worth of $706.46 million. The enterprise value is $459.04 million.
Important Dates
The next estimated earnings date is Thursday, July 10, 2025, before market open.
Earnings Date | Jul 10, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
KALV has 49.72 million shares outstanding. The number of shares has increased by 37.13% in one year.
Current Share Class | 49.72M |
Shares Outstanding | 49.72M |
Shares Change (YoY) | +37.13% |
Shares Change (QoQ) | +12.73% |
Owned by Insiders (%) | 1.61% |
Owned by Institutions (%) | 69.69% |
Float | 29.06M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 4.85 |
P/TBV Ratio | 4.87 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.44, with a Debt / Equity ratio of 0.04.
Current Ratio | 10.44 |
Quick Ratio | 10.25 |
Debt / Equity | 0.04 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -63.84 |
Financial Efficiency
Return on equity (ROE) is -150.50% and return on invested capital (ROIC) is -91.84%.
Return on Equity (ROE) | -150.50% |
Return on Assets (ROA) | -58.15% |
Return on Invested Capital (ROIC) | -91.84% |
Return on Capital Employed (ROCE) | -72.46% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.17M |
Employee Count | 150 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, KALV has paid $4.25 million in taxes.
Income Tax | 4.25M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +21.66% in the last 52 weeks. The beta is -0.02, so KALV's price volatility has been lower than the market average.
Beta (5Y) | -0.02 |
52-Week Price Change | +21.66% |
50-Day Moving Average | 12.22 |
200-Day Moving Average | 10.93 |
Relative Strength Index (RSI) | 65.65 |
Average Volume (20 Days) | 543,937 |
Short Selling Information
The latest short interest is 6.11 million, so 12.29% of the outstanding shares have been sold short.
Short Interest | 6.11M |
Short Previous Month | 5.86M |
Short % of Shares Out | 12.29% |
Short % of Float | 21.03% |
Short Ratio (days to cover) | 12.39 |
Income Statement
Revenue | n/a |
Gross Profit | -81.07M |
Operating Income | -181.42M |
Pretax Income | -126.64M |
Net Income | -175.87M |
EBITDA | -180.52M |
EBIT | -181.42M |
Earnings Per Share (EPS) | -$3.72 |
Full Income Statement Balance Sheet
The company has $253.20 million in cash and $5.78 million in debt, giving a net cash position of $247.42 million or $4.98 per share.
Cash & Cash Equivalents | 253.20M |
Total Debt | 5.78M |
Net Cash | 247.42M |
Net Cash Per Share | $4.98 |
Equity (Book Value) | 145.13M |
Book Value Per Share | 2.93 |
Working Capital | 241.74M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$127.65 million and capital expenditures -$168,000, giving a free cash flow of -$127.82 million.
Operating Cash Flow | -127.65M |
Capital Expenditures | -168,000 |
Free Cash Flow | -127.82M |
FCF Per Share | -$2.57 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
KALV does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -37.13% |
Shareholder Yield | -37.13% |
Earnings Yield | -24.89% |
FCF Yield | -18.09% |
Analyst Forecast
The average price target for KALV is $24.83, which is 74.74% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $24.83 |
Price Target Difference | 74.74% |
Analyst Consensus | Strong Buy |
Analyst Count | 8 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |